Chemours Co Stock Return On Asset
| CC Stock | USD 25.91 0.57 2.15% |
Chemours Co fundamentals help investors to digest information that contributes to Chemours' financial success or failures. It also enables traders to predict the movement of Chemours Stock. The fundamental analysis module provides a way to measure Chemours' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemours stock.
The current year's Return On Assets is expected to grow to -0.03. Chemours | Return On Asset |
Chemours Co Company Return On Asset Analysis
Chemours' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Chemours Return On Asset | 0.0529 |
Most of Chemours' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemours Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Chemours Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Chemours is extremely important. It helps to project a fair market value of Chemours Stock properly, considering its historical fundamentals such as Return On Asset. Since Chemours' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemours' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemours' interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Chemours Total Assets
Total Assets |
|
Based on the latest financial disclosure, Chemours Co has a Return On Asset of 0.0529. This is 92.85% lower than that of the Chemicals sector and 97.11% lower than that of the Materials industry. The return on asset for all United States stocks is 137.79% lower than that of the firm.
Chemours Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemours' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemours could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics of similar companies.Chemours is currently under evaluation in return on asset category among related companies.
Chemours Current Valuation Drivers
We derive many important indicators used in calculating different scores of Chemours from analyzing Chemours' financial statements. These drivers represent accounts that assess Chemours' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemours' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.0B | 3.0B | 4.1B | 4.8B | 4.7B | 3.6B | |
| Enterprise Value | 7.8B | 6.4B | 7.3B | 7.5B | 7.2B | 5.3B |
Chemours Fundamentals
| Return On Equity | -0.26 | ||||
| Return On Asset | 0.0529 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 7.04 B | ||||
| Shares Outstanding | 148.88 M | ||||
| Shares Owned By Insiders | 0.59 % | ||||
| Shares Owned By Institutions | 77.00 % | ||||
| Number Of Shares Shorted | 4.88 M | ||||
| Price To Earning | 25.49 X | ||||
| Price To Book | 5.35 X | ||||
| Price To Sales | 0.65 X | ||||
| Revenue | 6.03 B | ||||
| Gross Profit | 1.62 B | ||||
| EBITDA | 220 M | ||||
| Net Income | (238 M) | ||||
| Cash And Equivalents | 1.1 B | ||||
| Cash Per Share | 7.73 X | ||||
| Total Debt | 4.3 B | ||||
| Debt To Equity | 2.94 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | 4.96 X | ||||
| Cash Flow From Operations | 556 M | ||||
| Short Ratio | 1.37 X | ||||
| Earnings Per Share | (1.60) X | ||||
| Price To Earnings To Growth | 1.67 X | ||||
| Target Price | 31.44 | ||||
| Number Of Employees | 6.2 K | ||||
| Beta | 2.02 | ||||
| Market Capitalization | 3.94 B | ||||
| Total Asset | 8.25 B | ||||
| Retained Earnings | 1.78 B | ||||
| Working Capital | 1.35 B | ||||
| Current Asset | 2.3 B | ||||
| Current Liabilities | 1.47 B | ||||
| Annual Yield | 0.04 % | ||||
| Five Year Return | 3.59 % | ||||
| Net Asset | 8.25 B | ||||
| Last Dividend Paid | 1.0 |
About Chemours Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemours Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
| 0.61 | DNMR | Danimer Scientific Financial Report 8th of May 2024 | PairCorr |
| 0.58 | ECL | Ecolab Inc Financial Report 7th of May 2024 | PairCorr |
| 0.55 | CMT | Core Molding Technologies Financial Report 14th of May 2024 | PairCorr |
| 0.51 | ASH | Ashland Global Holdings Financial Report 7th of May 2024 | PairCorr |
| 0.5 | CBT | Cabot Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Chemours Piotroski F Score and Chemours Altman Z Score analysis. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.